BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1874560)

  • 1. High susceptibility of cataract Shionogi (CTS) mice to passive anaphylactic shock mediated by allogeneic IgE and IgG1 monoclonal antibodies.
    Harada M; Nagata M; Takeuchi M; Makino S; Aburahi S
    Immunol Invest; 1991 Jun; 20(3):305-15. PubMed ID: 1874560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-dependent difference in susceptibility to IgE antibody- and IgG1 antibody-mediated passive anaphylactic shock in the mouse.
    Harada M; Nagata M; Takeuchi M; Ohara T; Makino S; Watanabe A
    Immunol Invest; 1991; 20(5-6):515-23. PubMed ID: 1791039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressive effects of antihistaminic and/or anti-PAF agents on passive anaphylactic shock in mice sensitized with allogeneic monoclonal IgE and IgG1 antibodies and hyperimmune serum.
    Kimura S; Watanabe A; Takeuchi M; Nagata M; Harada M
    Immunol Invest; 1998 Dec; 27(6):379-93. PubMed ID: 9845423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effect of a PAF antagonist CV-3988 on active and passive anaphylactic shock in various mouse strains.
    Arimura A; Harada M
    Lipids; 1991 Dec; 26(12):1386-90. PubMed ID: 1819738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune deficiency of cataract Shionogi (CTS) mouse. II. Impaired in vivo T cell-mediated immune response.
    Yagi H; Nagata M; Takeuchi M; Watanabe A; Arimura A; Hashimoto S; Makino S; Harada M
    Immunol Invest; 1990; 19(5-6):493-505. PubMed ID: 2074115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strain difference and mode of inheritance of the susceptibility to passive cutaneous anaphylaxis mediated by allogeneic IgE antibody in the mouse.
    Harada M; Misaki R; Fukushima H; Nagata M; Makino S
    Immunol Invest; 1989 Jun; 18(5):723-35. PubMed ID: 2737701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of passive cutaneous anaphylaxis (PCA) and reversed PCA by rat IgE antibody in the mouse.
    Harada M; Nagata M; Takeuchi M
    Experientia; 1988 May; 44(5):459-62. PubMed ID: 3131155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-IL-4 antibody inhibits antigen specific IgE response but fails to prevent chicken gamma globulin-induced active systemic anaphylaxis: evidence for the involvement of IgG antibodies.
    Lee HK; Lee HH; Park YM; Park HJ; Lee JH; Ha TY
    J Korean Med Sci; 1996 Apr; 11(2):111-7. PubMed ID: 8835757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of active and passive anaphylactic shock in the WBB6F1 mouse, a mast cell-deficient strain.
    Arimura A; Nagata M; Watanabe A; Nakamura K; Takeuchi M; Harada M
    Experientia; 1990 Jul; 46(7):739-42. PubMed ID: 2373200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and Fc gammaRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis.
    Miyajima I; Dombrowicz D; Martin TR; Ravetch JV; Kinet JP; Galli SJ
    J Clin Invest; 1997 Mar; 99(5):901-14. PubMed ID: 9062348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between specific IgE antibody and non-specific IgE in anaphylactic sensitization of mice and rats.
    Wyczółkowska J; Michoń T; Brzezińska-Błaszczyk E; Maśliński C
    Arch Immunol Ther Exp (Warsz); 1982; 30(1-2):17-23. PubMed ID: 7149922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of drug susceptibility of mouse active anaphylactic shock.
    Kimura S; Watanabe A; Nagata M; Niinomi Y; Harada M
    Immunol Invest; 1996; 25(5-6):425-34. PubMed ID: 8915680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passive sensitization of mice and rats with IgE antibodies.
    Wyczółkowska J; Marciniak T; Brzezińska-Błaszczyk E; Maśliński C
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):689-93. PubMed ID: 86339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaphylactic shock caused by immunoglobulin E sensitization after retreatment with the chimeric anti-interleukin-2 receptor monoclonal antibody basiliximab.
    Baudouin V; Crusiaux A; Haddad E; Schandene L; Goldman M; Loirat C; Abramowicz D
    Transplantation; 2003 Aug; 76(3):459-63. PubMed ID: 12923429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active and passive cutaneous anaphylaxis in WBB6F1 mouse, a mast cell-deficient strain.
    Arimura A; Nagata M; Takeuchi M; Watanabe A; Nakamura K; Harada M
    Immunol Invest; 1990 Jun; 19(3):227-33. PubMed ID: 2365426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-IL-4 monoclonal antibody prevents antibiotics-induced active fatal anaphylaxis.
    Park JS; Choi IH; Lee DG; Han SS; Ha TY; Lee JH; Lee WH; Park YM; Lee HK
    J Immunol; 1997 May; 158(10):5002-6. PubMed ID: 9144520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgE knock-in mice suggest a role for high levels of IgE in basophil-mediated active systemic anaphylaxis.
    Lübben W; Turqueti-Neves A; Okhrimenko A; Stöberl C; Schmidt V; Pfeffer K; Dehnert S; Wünsche S; Storsberg S; Paul S; Bauer S; Riethmüller G; Voehringer D; Yu P
    Eur J Immunol; 2013 May; 43(5):1231-42. PubMed ID: 23423996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TH1-promoting DNA immunization against allergens modulates the ratio of IgG1/IgG2a but does not affect the anaphylactic potential of IgG1 antibodies: no evidence for the synthesis of nonanaphylactic IgG1.
    Hochreiter R; Ferreira F; Thalhamer J; Hammerl P
    J Allergy Clin Immunol; 2003 Sep; 112(3):579-84. PubMed ID: 13679818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of anaphylactic IgG1 antibody production by IL-4 and IL-10.
    Silva AS; Cavalcante LT; Faquim-Mauro EL; Macedo MS
    Int Arch Allergy Immunol; 2006; 141(1):70-8. PubMed ID: 16804329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of disodium 4-chloro-2-iminodibenzoate (CCA) on IgE levels and anaphylactic shock.
    González R; Carbajal D; Wyczolkowska J
    Agents Actions; 1989 Nov; 28(3-4):168-72. PubMed ID: 2596370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.